Drug Quality and Security Act in public interest--It offers providers and patients better information about compounded drugs by directing FDA to make a list of FDA-regulated outsourcing facilities available on FDA’s website, requiring detailed labeling on compounded drugs, and prohibiting false and misleading advertising.

The words were chilling: Deadly medical scandal. Fungal meningitis. Contaminated steroids. Rare brain infection. The mold exserohilum rostratum.
In August 2012 people were getting sick and reporting common symptoms. Then people started dying — especially in Tennessee and Michigan. The cause was a mystery. The U.S. Centers for Disease Control and Prevention traced the outbreak to the New England Compounding Center in Massachusetts
continue to read here

Maryland Board of Pharmacy Next board Meeting December 18, 2013 no agenda posted yet

The next public board meeting will beWEDNESDAY DECEMBER 18th, 2013 at the Board of Pharmacy 

Maryland Board of Pharmacy Rule Changes to Nonresident Pharmacy Permit Holders

IMPORTANT NOTICE TO NONRESIDENT PHARMACY PERMIT HOLDERS

Maine Board of Pharmacy Statement of Concern on Personal Importation of Prescription Drugs from International Mail Order Prescription Pharmacies

Proposals Adopted and effective dates Laws enacted by the 126th Maine Legislature take effect on October 9, 2013.
Rulemaking	Proposals Adopted and effective dates
Important Notices/Reminders	ME Board of Pharmacy Statement of Concern on Personal Importation of Prescription Drugs from International Mail Order Prescription Pharmacies

Fifth Question of the Day December 1, 2013 Can a pharmacist serve on both the Oklahoma State Pharmacy Board and the the Board of the Oklahoma Pharmacists Association at the same time? ff this is permissible, should it be?

OKLAHOMA PHARMACISTS
OKPharmPAC

BOARD OF DIRECTORS

TERMS EXPIRE –
Greg Heunergardt, Chairman
Shattuck, OK
Work: (580) 938-2854
medicdrug@yahoo.com

Mark Deevers, Vice Chairman
Elgin Pharmacy
Elgin, OK
Work: (580) 492-5007
mdeev@tds.net  

Phil Woodward, Secretary/Treasurer
Oklahoma City, OK
Work: (405) 557-5772
Home: (405) 373-1983
pwoodward4@cox.net  

Bob Dishman
Dishman Pharmacy
Lawton, OK
Work: (580) 353-8560
bdishman@dishmanpharmacy.com

Dorothy Gourley
Ardmore, OK
Work:  (405) 205-8192
Home: (580) 223-8783 
dotrx1967@cableone.net 

 

Members of the Board

 July 2013 - June 2014

Stephen Dudley	President / Public Member	Edmond	co-terminous with Governor
Mr. Greg Adams, D.Ph.	Vice-President	Clinton	2011-2016
Mr. John Lassiter, D.Ph.	Member	Del City	2004-2014
Mrs. Dorothy Gourley, D.Ph.	Member	Ardmore	2005-2015
Mr. James O. Spoon, D.Ph.	Member	Sand Springs	2012-2017
Mr. Justin Wilson, D.Ph.	Member	Midwest City	2013

Oklahoma Pharmacists Association Makes Available 2013 Oklahoma Opioid Dispensing Guidelines

2013 Oklahoma Opioid Dispensing Guidelines

Oklahoma Board of Pharmacy How to Verify a Pharmacists, Technican, Pharmacies or Facilities

Inquire about Pharmacists, Interns or Technicans

Inquire about Pharmacies Retail Charitable Non-Resident Hospital & Drug Room RMOP

Inquire about Facilities Manufacturers, Packagers, Wholesalers Medical Gas Distributors & Suppliers found here

Oklahoma Board of Pharmacy Minutes for October 24, 2013 Meeting

October 24, 2013

Kudos to Oklahoma State Board of Pharmacy in OSBP v. Trinity Apothecary #99-6362 – Case No. 1222 for $15,000 fine

OSBP vs. Trinity Apothecary #99-6362 – Case No. 1222:

The Board was called to order by President Dudley to hear the case of Trinity Apothecary.

Tesh Patel, D.Ph. and owner of Trinity Apothecary was present and chose to appear without Counsel.

Chief Compliance Officer, Cindy Hamilton testified for the Board. Assistant Attorney General, Brinda

White prosecuted for the Board.

Ms. White presented the Board with the Complaint for review. The Respondent had been

charged with multiple violations of state and federal regulation and rules including shipping

prescriptions into the state without an Oklahoma license and without submitting those prescriptions that were CDS to the Oklahoma Prescription Monitoring Program (PMP). The Respondent has since obtained a non-resident pharmacy license in the State of Oklahoma.

Motion was made by Dr. Greg Adams and seconded by Dr. Dorothy Gourley that based on the clear and convincing evidence presented the Respondent be found guilty on all five (5) counts.

Motion passed on roll call vote.

Motion was made by Dr. Greg Adams and seconded by Dr. Dorothy Gourley that the

Respondent’s license be placed on probation for three (3) years until October 24, 2016. The

Respondent is ordered to pay a fine of $3,000.00 per count for a total of $15,000.00 which is due on November 15, 2013. The Respondent must immediately obtain a license from the Oklahoma Bureau of Narcotics and Dangerous Drugs (OBNDD) and send a copy of this license to the Board. The

Respondent is to do late reporting of filled scripts for CDS to the OBNDD PMP. Motion passed on roll call vote.

Facts about the Oklahoma State Board of Pharmacy

The Board is also responsible for the licensing and regulation of all pharmacies, medical gas suppliers, medical gas distributors and prescription drug wholesalers, packagers and manufacturers that do business in the State of Oklahoma.  The Board maintains approximately 16,328 registrant records.
The Board has the power and duty to inspect all places handling drugs, medicines, chemicals and poisons.  The Board is charged with the enforcement of federal and state controlled dangerous substance and prescription drug laws.  There are approximately 1,538 licensed outlets in the state which are inspected by the Board.
The Board investigates complaints concerning pharmacists, technicians and interns as well as pharmacies, medical gas suppliers and distributors, and prescription drug wholesalers, packagers and manufacturers.  The Board conducts hearings on all types of registrants and has the authority to reprimand, fine, suspend or revoke licenses and permits.  The Board also reviews and approves continuing education programs that pharmacists are required to complete in order to renew their license
quoted from here

Louisiana Board of Pharmacy Compounding for Prescriber's Use Rule Proposal Considered by Regualtion Revision Committee on November 13, 2013

2013-1.2 ~ Compounding for Prescriber's Use  [Source: Regulatory Proposal 2013-E]
               01-29-2013     Board issued Declaration of Emergency & Emergency Rule, to become effective on 01-31-2013.
               01-30-2013     Distributed required Notice of Emergency to Offices of the Governor, Attorney General, President of the Senate, Speaker of the House of Representatives, and Director of the Louisiana Register.
               01-30-2013     Distributed electronic Notice of Rulemaking Activity to all pharmacies, all pharmacists, and List of Interested Parties.
               05-29-2013     Board re-issued Declaration of Emergency & Emergency Rule, effective immediately.
               05-30-2013     Distributed required Notice of Emergency Rule to Offices of the Governor, Attorney General, President of the Senate, Speaker of the House of Representatives, and Director of the Louisiana Register.
               06-01-2013     Distributed electronic Notice of Rulemaking Activity to all pharmacies, all pharmacists, and List of Interested Parties.
               09-27-2013     Board re-issued Declaration of Emergency & Emergency Rule, effective immediately.
               09-27-2013     Distributed required Notice of Emergency Rule to Offices of the Governor, Attorney General, President of the Senate, Speaker of the House of Representatives, and Director of the Louisiana Register.               09-27-2013     Distributed electronic Notice of Rulemaking Activity to all pharmacies, all pharmacists, and List of Interested Parties.              


2013-1.1 ~ Compounding for Prescriber's Use [Source: Regulatory Proposal 2013-D]
               12-13-2012     Board issued Declaration of Emgergency & Emergency Rule, effective immediately.
               12-16-2012     Distributed electronic Notice of Emergency Rule to all pharmacies, all pharmacists, and List of Interested Parties.
               12-17-2012     Distributed required Notice of Emergency to Office of the Governor, Office of the Attorney General, Office of the President of the Senate, Office of the Speaker of the House of Representatives, and Office of the Director of the Louisiana Register.
               01-18-2013     Louisiana Senate Committee on Health and Welfare rejected the emergency rule.  The effect of that decision was to void the December 13, 2012 emergency rule, effective immediately.  However, in recognition of the continuing potential risk, the legislative committee directed the Board to develop a replacement emergency rule with a different balance of risk vs benefit within two weeks.
               01-18-2013     Provided notice of legislative decision by distributing electronic Notice of Rulemaking Activity to all pharmacies, all pharmacists, and List of Interested Parties.
               01-29-2013     This project terminated with submission of replacement emergency rule, tracked as Regulatory Project 2013-1.2 (see above).


2013-1 ~ Compounding for Prescriber's Use [Source: Regulatory Proposal 2013-D]               01-20-2013     1st Report: Notice of Intent published in Louisiana Register
               02-27-2013     Public Hearing
               03-06-2013     Board considered comments; instructed staff to submit revised language for additional comment at a future public hearing.
               04-19-2013     Distributed electronic Notice of Rulemaking Activity to List of Interested Parties as well as all pharmacies and all pharmacists.
               04-20-2013     Potpourri Notice
               05-30-2013     Public Hearing
               08-15-2013     Board considered public comments and testimony, then remanded proposed rule back to Regulation Revision Committee for further consideration.
               11-13-2013     Scheduled for committee consideration

KUDOS! The Kansas Board of Pharmacy Gets New Website

Nov 08, 2013

The Board of Pharmacy website was recently changed on 11/1/13 in and effort to be more visually appealing and user friendly.  More content will be added to provide a comprehensive resource for all relevant information to support our mission statement.

 

quoted from here

Indiana Board of Pharmacy Disciplinary Action Against Pharmacies and Pharmacists Since September 1, 2013

Advanced Search for Board Pharmacy Board, Start Date 9/1/2013.

Last Name	First Name	MI	License	Board	Date	Type
Balaz	Jaroslav		26013971A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 102k
Adams	Shannon		26019548A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 146k
Miller	Richard	J	26019772A	Indiana State Board of Pharmacy	10/04/2013	Petition for Summary Suspension 54k
Miller	Richard	J	26019772A	Indiana State Board of Pharmacy	10/17/2013	ES Order 65k
McComb	Lori		26020464A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 168k
Kivett	Lewis Dean		26025227A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 63k
Jones	Fletcher		45017300A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 59k
McGuff Compounding Pharmacy Services	Inc., Santa Ana		64000260A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 67k
Pharmacorr LLC	Oklahoma City		64000364A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 64k
ESI Mail Pharmacy Service Inc	Bensalem		64000419A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 67k
U & I Inc.	USA, Vernon		64000690A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 64k
Rockwell Compounding Associates	Inc., Rye		64000707A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 65k
Moms Pharmacy Inc.	Melville		64000721A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 60k
New Albertson's	Inc. dba Savon.com, Carlsbad		64000775A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 60k
Park and King Pharmacy	Inc., Jacksonville		64000990A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 85k
Eastside Pharmacy	Inc., New York		64001060A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 63k
JHC Acquisition LLC dba Omnicare of Northern Illinois	Park Ridge		64001149A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 38k
Pet Meds and Beyond	Haileah		64001181A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 79k
Steltec Pharmacy dba Epharmpro Services	Brookhaven		64001184A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 65k
Cardinal Health 414	LLC, Lansing		64001221A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 65k
Institutional Pharmacy Solutions	LLC, Norfolk		64001267A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 65k
Stevens Pharmacy	Costa Mesa		64001283A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 58k
Pharmed Institutional Pharmacy	Westlake		64001288A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 60k
Direct Pharmacy Source	Inc., Sunrise		64001289A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 63k
Vincents Drug Store	Johns Island		64001356A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 63k
Village Fertility	Waltham		64001462A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 67k
Pharmacy Creations	New Jersey		64001516A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 76k
Beadle	Gabriel		67001428A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 80k
Wroblewski	Kathryn	T	67003506A	Indiana State Board of Pharmacy	10/17/2013	Motions 50k
Myers	Justin		67014356A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 93k
Urbanski	Alex		67017285A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 56k
Miller	Heather		67017557A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 58k
Fleming	Dennis		67018261A	Indiana State Board of Pharmacy	10/04/2013	Petition for Summary Suspension 50k
Fleming	Dennis		67018261A	Indiana State Board of Pharmacy	10/17/2013	ES Order 62k
Jones	Fletcher		67019952A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 59k
Miller	Lindsey		67020964A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 95k
Wolfe	Peyge		67022315A	Indiana State Board of Pharmacy	09/13/2013	Notice of Proposed Default 49k
Wolfe	Peyge		67022315A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 73k
Denning	Holly		67023115A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 60k
Oxymed Inc dba Wrencare	Fort Wayne		69000147A	Indiana State Board of Pharmacy	09/13/2013	Findings of Fact and Order 143k
Merkerson	Raven		99046339A	Indiana State Board of Pharmacy	09/13/2013	Notice of Proposed Default 50k
Merkerson	Raven		99046339A	Indiana State Board of Pharmacy	10/17/2013	Findings of Fact and Order 81k

Fourth Question of the Day December 1, 2013 How many cease and desist orders have been issued by states since the NECC outbreak? How many states have taken any enforcement action against any of the compounding pharmacies or pharmacists that the FDA found problems with?

Third Question of the Day December 1, 2013 How many compounding pharmacies blantantly advertise in a manner that shows criminal and civil activity such as fee spliting arrangements, etc.? What enforcement actions are state boards of pharmacy going to take to stop these actions? What actions are organizations that represent compounders going to take to help state boards of pharmacy to stop this illegal behavior?

Second Question of the Day December 1, 2013 Does the Florida Board of Pharmacy require or recommend that all sales employees are employees and not 1099 employees Do other state boards of pharmacy have rules or recommendations regarding this issue?

Anonymous

07-17-2013, 09:22 PM

Uh.... Didn't Supreme Medical Just run into issues with waiving of copays and sever ties to the compounding pharmacy they represented?
It won't be long until insurance companies figure out they are being billed huge sums of money for these creams and the compounding companies are pocketing a ton of money. Let's be real, how long until insurance companies put amstopmto this high priced practice?

They will just pay less. The payments are based on known generic quantities and concentrations. The higher the concentration and volume, the higher the price. Many insurance companies such as BCBS still reimburse, but instead of 120g and more at a time, they will only approve 30g or a weeks supply. There is nothing magical about the compounds or underhanded about the pharmacies (if they are billing appropriately). Happy hunting.

---

Anonymous

11-14-2013, 12:51 PM

Just to set the story straight, Florida Board of Pharmacy requires or recommends strongly that all sales people are employees because of pharmacy compliance issues. Most legit companies are contracting their employee sales team. Commissions ranges are factored as salary not a per transaction basis. Figure up to 20-25%

 

quoted from here

Is the real evidence of wrongdoing in the compounding pharmacy world found on chat boards like this one? Are people such as representatives being honest here?

Specialty Pharmacies - General Discussion

---

1. Bioscip
2. U.S. Bioservices
3. Independent Specialty Pharmacies: Friend or Forgettable?
4. Has anyone else tried PhoneConsultation.com ?
5. General Home Pharmacy
6. Specialty Pharmacy Reps (not pharma)
7. HHS/Accredo/Medco
8. IV Glutamine (Dipeptivin)
9. PLEASE,ATLANTA REPS, I NEED YOUR HELP
10. Compounding Pharmacy BEWARE
11. Specialty Pharmacy pay
12. Denied Party Screening
13. Sure Health/ Caresite in PA
14. Any1 know of Uvanta?
15. Hiring for Specialty Home Infusion Reps
16. Walgreens Specialty
17. Contract
18. Walgreen's Specialty Reporting
19. AR from Accredo in AL
20. Accredo fires many after record earning!
21. Hemophilia Spc Pharmacy and Homecare
22. Votrient distribution
23. What is it like working for Specialty pharmacy?
24. Apothecary Shop?
25. Publix
26. BIOSCRIP Sucks
27. Quality specialty pharmacy tampa fl pharmacy beware
28. ITSRX
29. Feds indict MedFusionRx , others for fraudulent billing, kickbacks
30. Top Specialty Pharmacy Providers
31. Rx Biotech - Background and Update
32. Prime Aid Clinical Specialty Pharmacy?
33. Territory Sales Executive with CVS/Caremark
34. CVS CAREMARK
35. Any Body Know About Medi-Stat
36. Better job Specialty Pharmacy or Oncology
37. Please help. Are there any decent sp. caremark has been awful
38. Curascript/Accredo will Own the SP Market
39. General Question
40. General Question
41. Prosperity
42. Diplomat Pharmacy - Need info
43. Specialty Pharmacy List?
44. ASL Pharmacy
45. Critical Care Systems
46. Seeing postings for ModernHealth
47. Commission
48. Curascript-Accredo
49. Axelacare
50. Pharmacy Kickbacks
51. DermaTran
52. Arj infusion ????
53. Ambient HealthCare
54. Home Infusion/Specialty Pharmacy Territory Manager
55. SinuScience Network
56. BioRx
57. ModernHealth
58. Axium
59. Optimal Pain Control OPCRX
60. BioMed Pharmaceuticals?
61. Focused Pain Relief
62. Florida Pharmacy Solutions
63. script dispense
64. In need of Great Compound Pharmacy
65. Infinity Compounding Solutions
66. PHYSICIAN SPECIALTY COMPOUNDING LLC?
67. No BS here, looking for a compounding deal
68. 1099 Compounding Commissions?
69. IPSEN Makers of DYSPORT lays off 85% of employees
70. Guardian Pharmacy
71. any regrets from pharma?
72. BriovaRx
73. Amber Pharmacy
74. Being Acquired by BioScrip
75. Infusion Partners
76. Prescription Dynamics
77. CVS Caremark - GIVE ME A BREAK
78. Accredo-CuraScripts vs others?
79. Summerton??
80. Will this industry survive??
81. Medimix
82. CVS Caremark
83. Magellan acquires Partners Rx and their leadership team
84. Maxor Natl Pharmacy & IV Solutions
85. Coram acquired by CVS

The Law of Veterinary Medicine: AVMA Links to Compounding information

The Law of Veterinary Medicine: AVMA Links to Compounding information: Compounding AVMA Regulatory Brief - FDA Roundtable on Compounding  (December 13, 2012) AVMA Letter to FDA regarding compounding  (...

Pharmacy Practice News - Specialty Pharm ‘Carve-out’ May Be Eased by UHC Plan

Pharmacy Practice News - Specialty Pharm ‘Carve-out’ May Be Eased by UHC Plan

Pharmacy Practice News - ‘White Bagging’ of Specialty Drugs Draws Some Ire

Pharmacy Practice News - ‘White Bagging’ of Specialty Drugs Draws Some Ire

Question of the Day December 1, 2013 Should there be global anti-doping rules that apply to the horse racing industry?

BBC Inside track on doping scandal - key questions for racing

Rumours and whispers whirl around horse racing like few other sports, and perhaps never more so than now, as it deals with the racehorse doping scandal.

Within the past fortnight, Mahmood Al Zarooni has been banned for eight years after admitting giving anabolic steroids to 15 horses, while fellow Newmarket trainer Gerard Butler faces a separate British Horseracing Authority (BHA) inquiry after nine of his stable tested positive.
continue to read here

NPR Story Sheds A lot of Light--Routine On U.S. Racetracks, Horse Doping Is Banned In Europe

 

 by Eleanor Beardsley

April 23, 2013

 

At the famous Hippodrome de Longchamp just outside of Paris this month, crowds came to cheer and bet on the sleek thoroughbreds that opened horse racing season by galloping down the verdant turf course.
Horse racing in Europe is different from the sport in the U.S., from the shape and surface of the track to race distances and the season itself. Another big difference is doping.
Drugs are not allowed in European horse races. But in America, they aren't just legal, they're widely used — particularly furosemide, better known as Lasix. The drug helps prevent horses' lungs from bleeding during races.

Enlarge imagei

Gina Rarick, an American horse trainer who works in France, says U.S. horse racing is out of step with the rest of the world.

                    

 

Gina Rarick, an American horse trainer in France, is grooming a horse at her stables in Maison Lafitte, lush horse country west of Paris. Rarick feels the practice of administering Lasix is ruining the sport in America.
"Every horse in America starts his day with a shot or two in the neck. I'm sorry, but it's wrong. It's just wrong." she says. "The Americans ... have these horror stories about, 'Oh, if we don't use Lasix they're gonna bleed to death and drop in front of people.' ... It's ridiculous. We don't use Lasix in the rest of the world."
Last month, the American horse Animal Kingdom, winner of the 2011 Kentucky Derby, had a two-length win at the Dubai World Cup. That victory, Rarick says, shows that a horse can run without Lasix.

listen to and read story here

Frog Juice: Horse Racing’s New Doping Scandal--dermorphin found in Louisiana, Oklahoma, and New Mexicio race horses

By Eliana Dockterman June 21, 2012

More than 30 horses have now tested positive for an illegal performance-enhancing substance that makes even the grossest doping scandal of human athletes pale in comparison. Apparently, horse owners have been paying chemists to squeeze frogs in South America and send the slime that drips off the amphibians’ backs to trainers in the United States. According to a report in the New York Times Tuesday, traffic in dermomorphin, a drug obtained from the skin of the Phyllomedusa sauvagei, commonly known as the waxy monkey tree frog, has racing officials across four states concerned.
Dermorphin has the twofold benefit of both numbing the pain a horse might feel from an injury and simultaneously rendering the animal hyperactive. “For a racehorse, it would be beneficial,” Craig W. Stevens, a professor of pharmacology at Oklahoma State University, told the Times. “The animal wouldn’t feel pain, and it would have feelings of excitation and euphoria.” The effects of this painkiller are even more powerful than morphine.
(MORE: Murder on the Backside: The Unseen World of the Kentucky Derby)
Dermorphin is only one of many doping methods that have plagued racetracks over the years, though it’s definitely the most exotic — narrowly beating out cobra venom, which has been used as a pain suppressant. But doping in horse racing is a century-old tradition, going at least as far back as a case in England in the nineteenth century in which a man was executed for drugging a racehorse with arsenic. But in a sport in which fans are becoming increasingly concerned over animals’ welfare and the methods used to train them — not excluding this year’s triple crown favorite, I’ll Have Another, recently scratched from the Belmont Stakes — its a blow racing officials aren’t eager to take. “It couldn’t have come at a worse time,” said the executive director of the Louisiana Racing Commission, Charles A. Gardiner III. “We’re fighting back federal intervention. We’re under attack and losing our fan base.”
Labs have found dermorphin in Louisiana, Oklahoma, and New Mexico, and regulators suspect its use in Texas. Though frog juice rumors had been circulating for a long time, officials had been unable to identify the substance until a lab in Denver recently found the correct testing procedure. No trainers have been formally charged yet, though racing regulators say we can expect a crackdown soon.
However, don’t expect a crackdown to deter cheating. Edward J. Martin, president of Racing Commissioners International, bemoaned the fact that as soon as you crackdown on one drug, trainers move on to using another.


Read more: Frog Juice: Horse Racing’s New Doping Scandal | TIME.com http://newsfeed.time.com/2012/06/21/frog-juice-horse-racings-new-doping-scandal/#ixzz2mFrEUGxk 

FEI information on doping

The use of substances with the potential to affect equine performance, health or welfare and/or with a high potential for misuse are contrary to the integrity of equestrian sport and the welfare of the horses.

The FEI provides a list of substances prohibited for use in horses competing at FEI events – the FEI Equine Prohibited Substances List. This list consists of two groups of substances: banned and controlled medication. Banned substances are not permitted for use in horses competing. Controlled medications are acknowledged as substances with therapeutic veterinary benefits but are not permitted during FEI events because of the potential for their misuse.

Testing programmes and protocols are implemented to detect the presence of prohibited substances in horses competing. Urine and/or blood samples from horses tested are sent by courier to one of five FEI Laboratories.

Negative blood and urine analysis results within the programme are updated regularly on the website for Groups I and II only and can be accessed here.

Before giving any substance to a horse competing at FEI events, athletes and their support personnel should always check, if it is prohibited under the FEI Rules by using the FEI Prohibited Substances database. They should work with veterinary advisers to establish a safe withdrawal time before competing. Horses must never compete unless they are fit to do so. During events, the administration of treatments and supportive therapies must be authorised by the veterinary delegate or commission before administration, using the appropriate veterinary form. The veterinary forms are available by clicking here.

For the latest Equine Anti-Doping and Controlled Medication Regulations in place, please click here.

For medication control at FEI events, please refer to the Veterinary Regulations. We have added for your convenience the following educational documents:  Athletes' Guide to Anti-Doping (pdf) and How Testing Works (pdf).
Information on FEI Laboratories:

• FEI Standard for Laboratories
• FEI Approved Laboratories

Other useful links:

• Prohibited Substances List
• List of Detection Times (pdf)

quoted here

The chats on the horse magazine blogs are going wild about the doping issues--maybe there is key evidence to be found here

for example see here

Scott Column: Congress looks at racing again

Anyone wondering why many people believe federal oversight is the only way horse racing can be effectively regulated — with uniform national standards regarding medication use, testing and enforcement — need look no further than comments made by Phil Hanrahan at last Thursday’s congressional subcommittee hearing on H.R. 2012, a bill better known as the Horse Racing Integrity and Safety Act of 2013.

continue to read here

VERY INTERESTING INFORMATION: Doping Problem In Horseracing Denied By Trainers

Thoroughbred racing’s drug problem was a myth, representatives of the horseracing industry recently told the U.S. Congress. Phil Hanrahan, the chief executive officer of the National Horsemen’s Benevolent and Protective Association, told Congress members that bringing in the United States Anti-Doping Agency to clean up the sport was addressing a problem that does not exist. However, a report by the California Horse Racing Board revealed that Bob Baffert, a Hall of Fame trainer, revealed on the same day that the trainer had been administering a thyroid hormone to every horse in his barn without ever checking to see if any of them had thyroid problems.

The California Horse Racing Board report revealed that thyroxine, the drug, was so routinely prescribed in the barn of Bob Baffert that it was dispensed for one of the horses a week after he had died. This report was made after an investigation was conducted by the California Horse Racing Board into the sudden deaths of seven horses trained by Baffert from 2011 to 2013. The report of the board found no evidence that California Horse Racing Board rules or regulations have been violated. In the meanwhile, Baffert declined to answer why he gave thyroxine to every horse in his barn if he did not know if the drug was required by the horses. The trainer wrote on Twitter, “I’m gratified that C.H.R.B. completed its investigation & found there was no wrongdoing.”

The report revealed that Baffert acknowledged directing his veterinarians to use the drug on all his horses. It was also disclosed that it was the trainer who asked his veterinarians to prescribe it, which is in conflict with the policy of the American Association of Equine Practitioners, the industry’s most influential veterinary group. According to the American Association of Equine Practitioners, treatments should be based upon a specific diagnosis and administered in the context of a valid and transparent owner-trainer-veterinarian relationship.

The investigators were told by Baffert that he believed the drug would help “build up” horses at his barn. The trainer remarked he stopped administering thyroxine to his horses after the seventh horse died last March. The CHRB report said thyroxine can cause “cardiac alterations” in horses according to one study. C.H.R.B.’s equine medical director, Dr. Rick Arthur, summarizing his report to the board that he had no conclusive explanation of how seven horses belonging to one trainer dropped dead during a period of sixteen months. He added that it is extremely abnormal statistically and went on to say that it does say there is something wrong here despite the fact that we couldn’t find anything.

In another development, three thoroughbred trainers (David Wells, Sam Webb, and Patricia Anne Rogers) were arrested and charged in federal court a day after a congressional hearing on doping in horse racing. The three trainers have accused of devising a scheme to defraud those betting on thoroughbred races at Penn National Race Course in Grantville by administering banned substances to horses within 24 hours of a race. If convicted, they face up to 20 years in prison and a $250,000 fine.

quoted from here

Rep seeks tough pharmacy watch --Massachusetts predicts it will have the model legislaton for the rest of the states; IACP “IACP supports state efforts to strengthen oversight and inspection of compounding pharmacies,” the IACP said in the statement. “We also seek to ensure that states commit adequate resources to state oversight agencies, which the Massachusetts legislation does.”

December 1, 2013

Massachusetts lawmakers must step up in the face of lax federal oversight to protect patients from contaminated drugs, which last year spawned a deadly fungal meningitis outbreak linked to a Framingham compounding pharmacy, according to a state legislator leading the charge for tougher laws.
“We went in with the understanding that we were going to be on a heavier hook than the feds,” said state Rep. Jeffrey Sanchez (D-Jamaica Plain), chairman of the Joint Committee on Public Health. “This just confirms it.”
President Obama signed a compounding pharmacy bill into law last week, but the federal legislation lacks any real oversight because it calls for large-scale compounding pharmacies to register on a voluntary basis with the FDA for inspections.
Tainted steroid injections from the now-shuttered New England Compounding Center have been blamed for the fungal meningitis outbreak that killed 64 people and infected 751 others in 20 states.
Sanchez, who soon will head into a conference committee to sort out differences between his House bill and a Senate version, said he has high hopes lawmakers will hammer out a deal to protect patients.
“When we come out with the bill I feel confident that we will be able to get at this so it doesn’t happen again. The problem with NECC was ... there was no reporting protocol,” Sanchez said. “If something happens like what happened with NECC and you get sick, you’ll be able to contact someone.”
State lawmakers also pumped more than $1 million into this year’s budget to hire more regulators for surprise inspections, 
Sanchez said.
The International Academy of Compounding Pharmacists released a statement saying the group does not believe a voluntary approach protects the public.
“IACP supports state efforts to strengthen oversight and inspection of compounding pharmacies,” the IACP said in the statement. “We also seek to ensure that states commit adequate resources to state oversight agencies, which the Massachusetts legislation does.”
Sanchez said he’s not feeling pressure from lobbyists to radically alter the legislation, which could come up for a vote in January.
“I think there is a general acceptance and understanding that change is coming relative to compounding pharmacies,” Sanchez said. “This bill was set up as one of the toughest in the country. We’ll come out with a model that can be used for the rest of the country.”
quoted from here

Illinois Board of Pharmacy September 2013 Meeting Minutes Approved

read here

Illinois Board of Pharmacy Recent Disciplinary Action

PHARMACY

Jenae Dodd, Terre Haute, IN

– pharmacy technician license (049-198563) placed

in refuse to renew status for pleading guilty to felon

y retail theft after diverting controlled

substances, non-prescription substances, and United

States currency from her former employer.

Doretta Fitzpatrick, Norridge

– pharmacy technician license (049-091714) placed

in refuse to renew status due to unprofessional conduct

 related to diverting a controlled substance

from an Osco pharmacy's controlled substance invent

ory for the purpose of self medication.

Melany Laird, DeKalb

– pharmacy technician license (049-170296) placed

in a refuse to renew status due to being found guilty of Unlawful Possession of a Controlled Substance, a

Class 4 Felony, after admitting to diverting a larg

e volume of controlled substances from her

former employer.

Christina Pallack, Normal

– pharmacy technician license (049-203939) revoked

afterthe Department received information that she was te

rminated from her employment for theft.

Robert Blanford, Frisco, TX

– pharmacist license (051-290940) placed in refuse

to renew status after being disciplined by the state of Texas. 

quoted from here

Idaho Board of Pharmacy Compounding Rules Draft

Draft Rule Dockets:

Compounding Rules 27-0101-1301

Rules 27-0101-1207

Positive ID Rules 27-0101-1302

Draft Bills:

Wholesalers

Controlled Substance Database

Controlled Substance schedules

2013 Rules & Statute Changes